Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Sep-24 5:12 PM View:  | Lappe Mark Chief Executive Officer Director | Inhibrx Biosciences, Inc. (INBX) | 16-Sep-24 | Purchase | 13,037 | $17.13 | $223,324.00 | 1% 912.38K to 925.41K | |
| 16-Sep-24 5:12 PM View: | Lappe Mark Chief Executive Officer Director | Inhibrx Biosciences, Inc. (INBX) | 12-Sep-24 | Purchase | 26,963 | $15.05 | $405,793.00 | 3% 885.41K to 912.38K | |
| 12-Sep-24 5:14 PM View: | Vuori Kristiina Md Director | Inhibrx Biosciences, Inc. (INBX) | 11-Sep-24 | Purchase | 6,457 | $15.07 | $97,307.00 | 88% 7.32K to 13.78K | |
| 12-Sep-24 5:14 PM View: | Vuori Kristiina Md Director | Inhibrx Biosciences, Inc. (INBX) | 10-Sep-24 | Purchase | 179 | $15.00 | $2,685.00 | 3% 7.14K to 7.32K | |
| 03-Sep-24 5:31 PM View: | Lappe Mark Chief Executive Officer Director | Inhibrx Biosciences, Inc. (INBX) | 03-Sep-24 | Purchase | 20,000 | $15.81 | $316,263.00 | 2% 821.41K to 841.41K | |
| 03-Sep-24 5:31 PM View: | Lappe Mark Chief Executive Officer Director | Inhibrx Biosciences, Inc. (INBX) | 30-Aug-24 | Purchase | 10,000 | $14.02 | $140,200.00 | 1% 811.41K to 821.41K | |
| 03-Sep-24 5:31 PM View: | Lappe Mark Chief Executive Officer Director | Inhibrx Biosciences, Inc. (INBX) | 29-Aug-24 | Purchase | 10,000 | $14.03 | $140,300.00 | 1% 801.41K to 811.41K | |
| 03-Sep-24 4:27 PM View: | Vuori Kristiina Md Director | Inhibrx Biosciences, Inc. (INBX) | 29-Aug-24 | Purchase | 7,140 | $14.00 | $99,960.00 | 100% 0 to 7.14K | |
| 30-Aug-24 4:16 PM View: | Manhard Kimberly Director | Inhibrx Biosciences, Inc. (INBX) | 28-Aug-24 | Purchase | 10,000 | $13.98 | $139,800.00 | 100% 0 to 10.0K | |
| 26-Aug-24 4:26 PM View: | Forsyth Douglas Director | Inhibrx Biosciences, Inc. (INBX) | 23-Aug-24 | Purchase | 59,812 | $14.07 | $841,555.00 | 36% 164.75K to 224.56K | |
| 26-Aug-24 4:26 PM View: | Forsyth Douglas Director | Inhibrx Biosciences, Inc. (INBX) | 22-Aug-24 | Purchase | 15,188 | $12.89 | $195,773.00 | 10% 149.56K to 164.75K | |
| 22-Aug-24 4:29 PM View: | Lappe Mark Chief Executive Officer Director | Inhibrx Biosciences, Inc. (INBX) | 21-Aug-24 | Purchase | 12,945 | $12.93 | $167,379.00 | 2% 788.47K to 801.41K | |
| 22-Aug-24 4:29 PM View: | Lappe Mark Chief Executive Officer Director | Inhibrx Biosciences, Inc. (INBX) | 20-Aug-24 | Purchase | 27,055 | $12.97 | $350,903.00 | 4% 761.41K to 788.47K | |
| 24-Jun-24 5:27 PM View: | Kayyem Jon Faiz Director | Inhibrx Biosciences, Inc. (INBX) | 24-Jun-24 | Gift | 20,000 | -- | -- | 2% 1.16M to 1.18M | |
| 24-Jun-24 5:27 PM View: | Kayyem Jon Faiz Director | Inhibrx Biosciences, Inc. (INBX) | 24-Jun-24 | Gift | 89,050 | -- | -- | (8%) 1.18M to 1.09M | |
| 07-Jun-24 6:05 PM View: | Kayyem Jon Faiz Director | Inhibrx Biosciences, Inc. (INBX) | 05-Jun-24 | Purchase | 57,549 | $17.32 | $997,024.00 | 5% 1.09M to 1.15M | |
| 04-Jun-24 5:27 PM View: | Kayyem Jon Faiz Director | Inhibrx Biosciences, Inc. (INBX) | 04-Jun-24 | Purchase | 89,063 | $17.65 | $1,572,240.00 | 9% 1.0M to 1.09M | |
| 04-Jun-24 5:27 PM View: | Kayyem Jon Faiz Director | Inhibrx Biosciences, Inc. (INBX) | 03-Jun-24 | Purchase | 127,530 | $17.43 | $2,222,430.00 | 15% 876.27K to 1.0M | |
| 04-Jun-24 5:27 PM View: | Kayyem Jon Faiz Director | Inhibrx Biosciences, Inc. (INBX) | 31-May-24 | Purchase | 70,193 | $16.14 | $1,132,920.00 | 9% 806.08K to 876.27K | |
| 30-May-24 6:10 PM View: | Kayyem Jon Faiz Director | Inhibrx Biosciences, Inc. (INBX) | 29-May-24 | Grant | 818,575 | -- | -- | 100% 0 to 818.58K | |
| 30-May-24 6:09 PM View: | Eckelman Brendan P. Chief Scientific Officer | Inhibrx Biosciences, Inc. (INBX) | 29-May-24 | Grant | 513,888 | -- | -- | 100% 0 to 513.89K | |
| 30-May-24 6:10 PM View: | Lappe Mark Chief Executive Officer Director | Inhibrx Biosciences, Inc. (INBX) | 29-May-24 | Grant | 761,413 | -- | -- | 100% 0 to 761.41K | |
| 30-May-24 6:10 PM View: | Forsyth Douglas Director | Inhibrx Biosciences, Inc. (INBX) | 29-May-24 | Grant | 149,564 | -- | -- | 100% 0 to 149.56K | |
| 31-May-24 4:30 PM View: | Inhibrx, Inc. 10% Owner | Inhibrx Biosciences, Inc. (INBX) | 29-May-24 | Disposition (other) | 13,316,100 | -- | -- | (92%) 14.47M to 1.16M |
